BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10924982)

  • 1. The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?
    Wong JS; O'Neill A; Recht A; Schnitt SJ; Connolly JL; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):133-7. PubMed ID: 10924982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone.
    Galper S; Recht A; Silver B; Manola J; Gelman R; Schnitt SJ; Connolly JL; Harris JR
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1157-66. PubMed ID: 10613308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
    Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
    J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
    Shahar KH; Hunt KK; Thames HD; Ross MI; Perkins GH; Kuerer HM; Strom EA; McNeese MD; Meric F; Schechter NR; Sahin AA; Middleton LP; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1074-9. PubMed ID: 15234041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
    Chua B; Ung O; Taylor R; Boyages J
    ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.
    Hetelekidis S; Schnitt SJ; Silver B; Manola J; Bornstein BA; Nixon AJ; Recht A; Gelman R; Harris JR; Connolly JL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):31-4. PubMed ID: 10656369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and predictors of axillary lymph node metastases in invasive breast cancer.
    Chua B; Ung O; Taylor R; Boyages J
    ANZ J Surg; 2001 Dec; 71(12):723-8. PubMed ID: 11906387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes.
    Wong JS; Recht A; Beard CJ; Busse PM; Cady B; Chaffey JT; Come S; Fam S; Kaelin C; Lingos TI; Nixon AJ; Shulman LN; Troyan S; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):915-20. PubMed ID: 9369141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer.
    Gurleyik G; Gurleyik E; Aker F; Aktekin A; Emir S; Gungor O; Saglam A
    Acta Chir Belg; 2007 Jun; 107(3):284-7. PubMed ID: 17685254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.